- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07722793
EndoVascular Aneurysm Repair: Heart Remodeling and Aortic Stiffness Study (EVAR-HRAS)
Impact of Endovascular Abdominal Aortic Aneurysm Repair on Aortic Stiffness and Left Ventricular Remodeling
Abdominal aortic aneurysm (AAA) is associated with a high burden of cardiovascular morbidity and mortality. Although endovascular aneurysm repair (EVAR) has become the preferred treatment for many patients with infrarenal AAA because of its lower perioperative risk, its impact on arterial stiffness and cardiac function remains insufficiently understood. Experimental and clinical evidence suggests that endograft implantation may increase aortic stiffness by reducing aortic compliance, potentially altering ventricular-arterial coupling and contributing to left ventricular remodeling and dysfunction.
This prospective observational study aims to evaluate the effects of elective EVAR on aortic stiffness, left ventricular structure and function, and circulating biomarkers of myocardial stress and extracellular matrix remodeling. Patients with infrarenal AAA scheduled for elective EVAR will be assessed before the procedure and at 48 hours, 6 months, and 12 months after intervention. Aortic stiffness will be assessed using estimated carotid-femoral pulse wave velocity (cfPWV), while left ventricular function and remodeling will be evaluated by transthoracic echocardiography, including global longitudinal strain (GLS). Circulating NT-proBNP and MMP-3 concentrations will also be measured.
The study will provide insight into the cardiovascular effects of EVAR and may improve understanding of procedure-related changes in arterial stiffness and cardiac remodeling, thereby supporting better long-term cardiovascular risk assessment and postoperative management in patients undergoing EVAR.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Osijek, Croatia, 31000
- Department of Vascular Surgery, University Hospital Center Osijek
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients (≥18 years of age) with diagnosed abdominal aortic aneurysm (AAA) who are scheduled for elective endovascular aneurysm repair (EVAR)
- Patients eligible for EVAR according to current clinical guidelines and anatomical criteria
- Signed informed consent for participation in the study
- Ability to undergo scheduled follow-up examinations (baseline, early post-procedural assessment, and follow-up visits)
Exclusion Criteria:
- Emergency EVAR for ruptured or symptomatic abdominal aortic aneurysm
- Previous aortic repair or previous endovascular intervention involving the abdominal aorta
- Concomitant major cardiovascular surgery or intervention during the study period
- Severe hemodynamic instability or critical illness at the time of inclusion
- Active infection or acute inflammatory disease that may influence vascular or inflammatory biomarkers
- Malignancy with active treatment or life expectancy limiting follow-up
- Inability to provide informed consent
- Inability to complete planned follow-up assessments
- Known severe valvular heart disease or advanced heart failure
- Conditions affecting arterial stiffness measurements (e.g. atrial fibrillation, severe arrhythmias, inability to obtain reliable PWV measurements)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
EVAR patients
Patients undergoing endovascular aneurysm repair (EVAR) with assessment of arterial stiffness and cardiac function before the procedure and during follow-up (2 days, 6 months, and 12 months after EVAR).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in arterial stiffness after endovascular aneurysm repair (EVAR)
Time Frame: Baseline (pre-EVAR) to 12 months after EVAR (2 days, 6 months, 12 months)
|
Change in arterial stiffness after endovascular aneurysm repair (EVAR)
|
Baseline (pre-EVAR) to 12 months after EVAR (2 days, 6 months, 12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early and long-term changes in arterial stiffness after EVAR
Time Frame: Baseline, 2 days, 6 months, 12 months
|
Changes in PWV at 2 days, 6 months, and 12 months after EVAR compared with baseline.
|
Baseline, 2 days, 6 months, 12 months
|
|
Changes in cardiac function after EVAR
Time Frame: Baseline, 2 days, 6 months, 12 months
|
Changes in echocardiographic parameters of cardiac structure and function (LVEF, E/e', LA volume, LV volume, LA strain, LV strain etc.) following EVAR.
|
Baseline, 2 days, 6 months, 12 months
|
|
Changes in circulating biomarkers after EVAR
Time Frame: Baseline, 2 days, 6 months, 12 months
|
Changes in circulating biomarkers associated with vascular function, inflammation, and cardiovascular risk after EVAR.
|
Baseline, 2 days, 6 months, 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Ana Stupin, MD, PhD, Faculty of Medicine Osijek
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EVAR-HRAS Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysm
-
Karolinska University HospitalKarolinska Institutet; Swedish Heart Lung FoundationActive, not recruitingAortic Aneurysm | Aortic Aneurysm Abdominal | Abdominal AneurysmSweden
-
Assistance Publique - Hôpitaux de ParisUnknownSmall Abdominal Aortic Aneurysm | Abdominal Aortic Aneurysm,France
-
Karolinska University HospitalEnrolling by invitationAneurysm | Aortic Aneurysm | Abdominal Aortic Aneurysm, Ruptured | Aneurysm Abdominal | Abdominal Aortic Aneurysm Without RuptureSweden
-
EndologixActive, not recruiting1 Paravisceral Abdominal Aortic Aneurysm | 2 Juxtarenal Abdominal Aortic Aneurysm | 3 Pararenal Abdominal Aortic Aneurysm | 4 Complex Abdominal Aortic AneurysmsUnited States
-
University of TwenteNot yet recruitingAbdominal Aortic Aneurysm | Endovascular Abdominal Aortic Aneurysm Repair | Fenestrated Endovascular Aortic RepairNetherlands
-
Rijnstate HospitalCompletedAAA - Abdominal Aortic AneurysmNetherlands
-
Angiolutions GmbHRecruitingAneurysm, Abdominal AorticUzbekistan
-
University Hospital of LimerickCompleted
-
Medtronic CardiovascularCompletedAbdominal Aortic Aneurysms (AAA)United States
-
Vascutek Ltd.TerminatedAbdominal Aortic Aneurysms (AAA)United Kingdom, Netherlands, Switzerland, Spain, Germany, Belgium, Sweden, Canada, France, Italy, Austria, Monaco